The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-sev ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

When conventional treatments for moderate to severe atopic dermatitis become less effective, targeted therapies may help.

The misconception of eczema being contagious likely arises from its association with other infections that can occur among ...

These ten essentials keep my skin hydrated, soothed, and protected from inflammation, itchiness, and occasional scaliness.

During exam seasons or other stressful periods, her eczema inevitably flares up. When it gets too hot and humid and she ...

KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...